This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simon, B. E. Articles by Barry, R. A. Search for Related Content PubMed PubMed Citation Articles by Simon, B. E. Articles by Barry, R. A.

 Previous Article  |  Next Article 

Infection and Immunity, November 2003, p. 6372-6380, Vol. 71, No. 11
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.11.6372-6380.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

DNA Vaccination Protects Mice against Challenge with Listeria monocytogenes Expressing the Hepatitis C Virus NS3 Protein

Benjamin E. Simon,¹ Kenneth A. Cornell,^1, Tina R. Clark,¹ Sunwen Chou,^1,2 Hugo R. Rosen,^1,2,3 and Ronald A. Barry^1,2,3*

Department of Veterans Affairs Medical Center, Portland, Oregon 97239,¹ Departments of Medicine and Molecular Microbiology and Immunology,³ Oregon Health Sciences University, Portland, Oregon 97201²

Received 20 May 2003/ Returned for modification 24 June 2003/ Accepted 16 July 2003

The goal of this study was to develop a new surrogate challenge model for use in evaluating protective cell-mediated immune responses against hepatitis C virus (HCV) antigens. The use of recombinant Listeria monocytogenes organisms which express HCV antigens provides novel tools with which to assay such in vivo protection, as expression of immunity against this hepatotropic bacterial pathogen is dependent on antigen-specific CD8⁺ T lymphocytes. A plasmid DNA vaccine encoding a ubiquitin-NS3 fusion protein was generated, and its efficacy was confirmed by in vivo induction of NS3-specific, gamma interferon-secreting T cells following vaccination of BALB/c mice. These immunized mice also exhibited specific in vivo protection against subsequent challenge with a recombinant L. monocytogenes strain (TC-LNS3) expressing the NS3 protein. Notably, sublethal infection of naive mice with strain TC-LNS3 induced similar NS3-specific T-cell responses. These findings suggest that recombinant strains of L. monocytogenes expressing HCV antigens should prove useful for evaluating, or even inducing, protective immune responses against HCV antigens.

Editor: B. B. Finlay

Present address: AcryMed, Portland, OR 97223.

This article has been cited by other articles:

• Lin, Y., Kwon, T., Polo, J., Zhu, Y.-F., Coates, S., Crawford, K., Dong, C., Wininger, M., Hall, J., Selby, M., Coit, D., Medina-Selby, A., McCoin, C., Ng, P., Drane, D., Chien, D., Han, J., Vajdy, M., Houghton, M. (2008). Induction of Broad CD4+ and CD8+ T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5 . J. Virol. 82: 7492-7503 [Abstract] [Full Text]  
• Karayiannis, P., Main, J., Thomas, H. C. (2004). Hepatitis vaccines. Br Med Bull 70: 29-49 [Full Text]  
• Jiao, X., Wang, R. Y.-H., Qiu, Q., Alter, H. J., Shih, J. W.-K. (2004). Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes. J. Gen. Virol. 85: 1545-1553 [Abstract] [Full Text]